Limoneira Posts Downbeat Q3 Results, Joins Cooper Companies, Navan And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Robinhood To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday

Analysts cut targets for BOOT, MTN, SFIX, WU, NFLX and ROL; raised HOOD and STAA targets. SFIX upgraded to Neutral, NFLX to Buy.

BMO Capital Maintains Market Perform on American Eagle Outfitters, Raises Price Target to $20

BMO Capital analyst Kelly Crago maintains American Eagle Outfitters (NYSE:AEO) with a Market Perform and raises the price target from $18 to $20.

Shares of retail-related consumer discretionary companies are trading lower as energy prices remain elevated, a Fed rate hike on September 16 becomes base case, and traders assess the outlook for more monetary tightening in 2026 and 2027 ahead of the crucial holiday season.

VSXY Dips 10% in the Past Month: Is the Pullback an Opportunity?

Victoria's Secret (VSXY) shares have declined 10% despite strong Q2 results showing 9% comparable sales growth, expanded margins, and positive customer trends. However, the stock trades above its historical valuation while facing headwinds from tariffs, transportation costs, and increased marketing spending. Analysts recommend a cautious approach, suggesting the pullback improves entry price but doesn't eliminate execution risks.

B of A Securities Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $50

B of A Securities analyst Alec Stranahan maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $46 to $50.

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $34

JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $34.